Tudor Investment Corp
RPRX icon

Tudor Investment Corp’s Royalty Pharma RPRX Stock Holding History

Tudor Investment Corp’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32.2M Sell
671,680
-253,139
-27% -$11.1M 0.06% 253
2025
Q4 		$35.7M Buy
924,819
+60,984
+7% +$2.33M 0.07% 235
2025
Q3 		$30.5M Buy
863,835
+221,099
+34% +$8M 0.05% 290
2025
Q2 		$23.2M Sell
642,736
-85,000
-12% -$2.82M 0.05% 289
2025
Q1 		$22.7M Sell
727,736
-7,291
-1% -$231K 0.08% 179
2024
Q4 		$18.8M Buy
735,027
+226,274
+44% +$6M 0.07% 171
2024
Q3 		$14.4M Buy
508,753
+196,253
+63% +$5.44M 0.05% 279
2024
Q2 		$8.24M Buy
312,500
+296,452
+1,847% +$8.22M 0.04% 451
2024
Q1 		$487K Sell
16,048
-54,742
-77% -$1.61M ﹤0.01% 1658
2023
Q4 		$1.99M Sell
70,790
-138,083
-66% -$3.79M 0.02% 1098
2023
Q3 		$5.67M Buy
208,873
+147,933
+243% +$4.39M 0.06% 450
2023
Q2 		$1.87M Buy
+60,940
New +$2.06M 0.02% 924

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Tudor Investment Corp's RPRX Position: Q1 2026 in Review

Tudor Investment Corp reduced its Royalty Pharma (RPRX) stake by 27% in Q1 2026, selling an estimated $11.1M and leaving 671,680 shares worth $32.2M. The position accounts for 0.06% of the portfolio, ranked #253.

Tudor Investment Corp first reported a position in RPRX in Q2 2023 and has held it in 12 quarters since. The position peaked at $35.7M in Q4 2025. 587 funds tracked by Wall St. Rank hold RPRX as of Q1 2026.

  • Tudor Investment Corp held 671,680 shares of Royalty Pharma worth $32.2M as of Q1 2026.
  • Tudor Investment Corp sold 253,139 Royalty Pharma shares in Q1 2026, an estimated $11.1M.
  • Royalty Pharma made up 0.06% of Tudor Investment Corp's portfolio in Q1 2026, its #253 holding.
  • Tudor Investment Corp first reported a position in Royalty Pharma in Q2 2023 and has held it in 12 quarters since.
  • Tudor Investment Corp's Royalty Pharma position peaked at $35.7M in Q4 2025.
  • 587 funds tracked by Wall St. Rank held Royalty Pharma as of Q1 2026.

Based on Tudor Investment Corp's 13F filing for Q1 2026, filed 15 May 2026.